Welcome to LookChem.com Sign In|Join Free

CAS

  • or

100986-89-8

Post Buying Request

100986-89-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100986-89-8 Usage

Chemical Properties

White Solid

Uses

Levofloxacin intermediate.

Check Digit Verification of cas no

The CAS Registry Mumber 100986-89-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,9,8 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 100986-89:
(8*1)+(7*0)+(6*0)+(5*9)+(4*8)+(3*6)+(2*8)+(1*9)=128
128 % 10 = 8
So 100986-89-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H9F2NO4/c1-5-4-20-12-9(15)8(14)2-6-10(12)16(5)3-7(11(6)17)13(18)19/h2-3,5H,4H2,1H3,(H,18,19)/t5-/m0/s1

100986-89-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (L0238)  Levofloxacin Q-Acid  >98.0%(HPLC)(T)

  • 100986-89-8

  • 1g

  • 990.00CNY

  • Detail
  • TCI America

  • (L0238)  Levofloxacin Q-Acid  >98.0%(HPLC)(T)

  • 100986-89-8

  • 5g

  • 3,450.00CNY

  • Detail
  • Alfa Aesar

  • (H54086)  (S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 97+%   

  • 100986-89-8

  • 250mg

  • 373.0CNY

  • Detail
  • Alfa Aesar

  • (H54086)  (S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 97+%   

  • 100986-89-8

  • 1g

  • 1044.0CNY

  • Detail
  • Alfa Aesar

  • (H54086)  (S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 97+%   

  • 100986-89-8

  • 5g

  • 3723.0CNY

  • Detail
  • USP

  • (1362125)  Levofloxacin Related Compound B  United States Pharmacopeia (USP) Reference Standard

  • 100986-89-8

  • 1362125-35MG

  • 14,578.20CNY

  • Detail
  • Aldrich

  • (570877)  (S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid  97%

  • 100986-89-8

  • 570877-1G

  • 1,661.40CNY

  • Detail
  • Aldrich

  • (570877)  (S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid  97%

  • 100986-89-8

  • 570877-5G

  • 5,243.94CNY

  • Detail

100986-89-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Levofloxacin Carboxylic Acid

1.2 Other means of identification

Product number -
Other names Levofloxacin carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100986-89-8 SDS

100986-89-8Relevant articles and documents

Novel ofloxacin derivatives: Synthesis, antimycobacterial and toxicological evaluation

Dinakaran, Murugesan,Senthilkumar, Palaniappan,Yogeeswari, Perumal,China, Arnab,Nagaraja, Valakunja,Sriram, Dharmarajan

, p. 1229 - 1236 (2008)

Thirty novel 9-fluoro-2,3-dihydro-8,10-(mono/di-sub)-3-methyl-8-nitro-7-oxo-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acids were synthesized from 2,3,4,5-tetrafluoro benzoic acid and evaluated for in vitro and in vivo antimycobacterial activities against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant Mycobacterium tuberculosis (MDR-TB), and Mycobacterium smegmatis (MC2) and also tested for the ability to inhibit the supercoiling activity of DNA gyrase from mycobacteria. Among the synthesized compounds, 10-[2-carboxy-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-9-fluoro-2,3-dihydro-3-methyl-8-nitro-7-oxo-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid was found to be the most active compound in vitro with MIC99 of 0.19 μM and 0.09 μM against MTB and MTR-TB, respectively. In the in vivo animal model also the same compound decreased the bacterial load in lung and spleen tissues with 1.91 and 2.91 - log 10 protections, respectively, at the dose of 50 mg/kg body weight. Compound 10-[(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)]-9-fluoro-2,3-dihydro-3-methyl-8-nitro-7-oxo-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid was found to be the most active in the inhibition of the supercoiling activity of DNA gyrase with an IC50 of 10.0 μg/mL. The results demonstrate the potential and importance of developing new oxazino quinolone derivatives against mycobacterial infections.

Synthesis method of levofloxacin carboxylic acid (by machine translation)

-

, (2020/02/27)

The method comprises the following steps, mixing: dimethylaminopropyl methacrylate with an acid-binding agent in an organic solvent A, and then carrying out an amine exchange reaction A, to obtain N,N -tetrafluorobenzoyl - 3 3 3 3 3-dimethylaminopropyl A acrylate as shown in formula III B, in the reaction mixture A to obtain a mixture liquid, and a mixed solution 2 - (2, 3, 4, 5) - condensation reaction A; to obtain the compound. A. The reaction liquid L - is dissolved in an organic solvent, The reaction solution 2 - (2, 3, 4, 5) - is obtained by a condensation reaction with a mixture solution.) - The method comprises the following steps, (II). The method comprises the following steps of: adding B aminopropanol, to the reaction solution; and HCl, HOAc, H carrying out an amine exchange reaction with a mixed solution of N- propyl methyl acrylate. 2 The reaction of the acid system of O to give the levofloxacin carboxylic acid. of formula V prevents the preparation N,N - dimethylaminoethyl acrylate from being unstable and difficult, unsafe and expensive sodium ethoxide, to corrosion of the device. (by machine translation)

Environment-friendly method for preparing levofloxacin hydrochloride

-

Paragraph 0019; 0023; 0027, (2017/10/05)

The invention provides an environment-friendly method for preparing levofloxacin hydrochloride. The method comprises the following steps: preparing 3-(2-hydroxy-1-methyl-ethylamino)-2-(2,3,4,5-tetrafluorobenzoyl)-ethyl acrylate, preparing levo-oxy main naphthenic acid, and preparing the levofloxacin hydrochloride. The method provided by the invention is concise, low in production cost, high in product yield, good in quality, economic and environment-friendly, fewer three wastes are discharged, and most byproducts are effectively separated and recycled, so that the method is convenient for industrial production and has great popularization significance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100986-89-8